HealthEquity (NASDAQ:HQY) Earns “Outperform” Rating from Barrington Research
HealthEquity (NASDAQ:HQY – Get Free Report)‘s stock had its “outperform” rating reiterated by stock analysts at Barrington Research in a research note issued to investors on Friday,Benzinga reports. They presently have a $112.00 target price on the stock. Barrington Research’s price objective points to a potential upside of 14.98% from the company’s current price. A […]
HealthEquity (NASDAQ:HQY – Get Free Report)‘s stock had its “outperform” rating reiterated by stock analysts at Barrington Research in a research note issued to investors on Friday,Benzinga reports. They presently have a $112.00 target price on the stock. Barrington Research’s price objective points to a potential upside of 14.98% from the company’s current price. A […]
